tiprankstipranks
Trending News
More News >
Reckitt (GB:RKT)
LSE:RKT

Reckitt (RKT) AI Stock Analysis

Compare
324 Followers

Top Page

GB:RKT

Reckitt

(LSE:RKT)

Select Model
Select Model
Select Model
Outperform 76 (OpenAI - 4o)
Rating:76Outperform
Price Target:
6,729.00p
▲(12.56% Upside)
Reckitt's overall stock score reflects strong financial performance and strategic initiatives that support growth, particularly in emerging markets. While the valuation is a concern, the company's focus on profitability and shareholder returns through buybacks and dividends enhances its investment appeal.
Positive Factors
Emerging Markets Performance
Strong growth in emerging markets indicates Reckitt's ability to capitalize on expanding economies, enhancing long-term revenue potential and market presence.
Fuel for Growth Program
The program's success in reducing costs enhances operational efficiency, supporting margin sustainability and long-term profitability.
Strategic Divestment
Divesting non-core segments allows Reckitt to concentrate resources on high-margin brands, potentially boosting profitability and market focus.
Negative Factors
Revenue Growth Challenges
Declining revenue growth could pressure future profitability, indicating challenges in maintaining sales momentum across key markets.
North America Revenue Decline
Declining revenues in North America suggest potential market saturation or competitive pressures, impacting overall growth prospects.
Mead Johnson Nutrition Decline
The decline in Mead Johnson Nutrition sales highlights challenges in the nutrition segment, potentially affecting long-term revenue diversification.

Reckitt (RKT) vs. iShares MSCI United Kingdom ETF (EWC)

Reckitt Business Overview & Revenue Model

Company DescriptionReckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom, the United States, China, India, and internationally. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands. It also provides analgesics; sore throat medications; and hair removal products under the Nurofen, Strepsils, and Veet brands. In addition, the company offers fragrances and devices; water softeners; home cleaning products; dish washes; toilet cleaners; disinfectants; sprays, baits, and plug-ins for pest control; stain removals; fabric washing; and other hygiene products under the Air Wick, Calgon, Cillit Bang, Finish, Harpic, Lysol, Mortein, Vanish, and Woolite brands, as well as analgesics, adult nutrition products, iron-fortified hypoallergenic baby formula, products for joint issues, and infant and toddler nutrition products, as well as vitamins, minerals, and supplements under the Biofreeze, Airborne, Mead Johnson, Move Free, Enfamil, and Nutramigen brands. Further, it provides probiotics, sore throat pain relief products, Omega products, brain health support products, cleaning and carpet cleaning products, septic tank system treatment products, cough syrups, plant-based laundry products, probiotics, and lubricants under the Digestive Advantage, Cepacol, MegaRed, Neuriva, Easy-Off, RID-X, Delsym, Botanical Origin, Bodi-Ome, and K-Y brands. The company was founded in 1819 and is headquartered in Slough, the United Kingdom.
How the Company Makes MoneyReckitt generates revenue primarily through the sale of its branded consumer products in the health, hygiene, and nutrition sectors. The company's revenue model is based on a mix of direct-to-consumer sales, retail partnerships, and e-commerce platforms. Key revenue streams include the sale of over-the-counter health products, cleaning and disinfecting solutions, and nutritional supplements. Reckitt has established significant partnerships with retailers and distributors globally, which enhances its market reach and visibility. Additionally, the company's investment in research and development allows it to innovate and expand its product offerings, further driving sales and revenue growth.

Reckitt Earnings Call Summary

Earnings Call Date:Jul 24, 2025
(Q2-2025)
|
% Change Since: |
Next Earnings Date:Mar 05, 2026
Earnings Call Sentiment Neutral
The earnings call reflects a strong overall performance for Reckitt, highlighted by robust growth in Core Reckitt revenues and Emerging Markets, improved operating profit, and successful strategic initiatives. However, challenges remain with declines in North America and Self Care revenues, as well as underperformance in Essential Home and Mead Johnson Nutrition.
Q2-2025 Updates
Positive Updates
Core Reckitt Revenue Growth
Core Reckitt revenues grew 5.3% in Q2 and 4.2% for the half year, driven by strong performance in Emerging Markets.
Improved Operating Profit
Adjusted operating profit increased by 7% at constant exchange rates, with a margin increase of 110 basis points to 24.6%.
Emerging Markets Performance
Emerging Markets delivered 12.8% like-for-like growth for the half year and 14.9% in Q2, driven by strong performance in India, China, and Latin America.
Fuel for Growth Program
The Fuel for Growth program is delivering ahead of plan, contributing to a 190 basis point reduction in fixed costs in the first half.
Strategic Divestment
Reckitt announced an agreement to divest Essential Home, which will help focus on high-growth, high-margin Powerbrands.
Shareholder Returns
Reckitt increased the interim dividend by 5% and announced a GBP 1 billion share buyback program.
Negative Updates
Self Care Revenue Decline
Self Care revenue was slightly down due to the Mucinex shelf reset in the U.S., impacting overall performance.
North America Revenue Decline
North America like-for-like net revenue declined 1.7% in the half, with Q2 softer than Q1, primarily due to the Mucinex shelf reset.
Essential Home Performance
Essential Home saw a like-for-like net revenue decline of 6.5% for the half year, with challenges in improving performance.
Mead Johnson Nutrition Decline
Mead Johnson Nutrition like-for-like net revenue declined 3.3% in the half, affected by previous private label outages.
Company Guidance
In the recent call, Reckitt reported strong financial performance for the first half of 2025, with notable improvements across various metrics. Core Reckitt revenues increased by 5.3% in Q2, contributing to a 4.2% growth for the half year. The company achieved a 7% rise in adjusted operating profit and a 4.4% increase in EPS, driven by enhanced efficiency and cost benefits from the Fuel for Growth program. Market share gains were significant, with 59% of Core Reckitt's CMUs in hold gain territory, and the interim dividend was raised by 5%. The company's strategic divestment of Essential Home aims to refine its focus on high-growth Powerbrands. Looking forward, Reckitt has revised its Core Reckitt revenue growth target to over 4% for the full year, supported by strong emerging market performance and strategic investments.

Reckitt Financial Statement Overview

Summary
Reckitt exhibits solid financial health with strong profitability metrics and efficient cash flow management. However, there are concerns regarding revenue growth and declining net income, which could pressure future profitability.
Income Statement
75
Positive
Reckitt has shown a consistent ability to maintain strong gross and net profit margins. The gross profit margin for 2024 was 60.7%, reflecting efficient cost management. However, revenue has seen a slight decline year-over-year, decreasing by approximately 3% from 2023 to 2024. EBIT and EBITDA margins remain robust at 17.1% and 20.9%, respectively, although there has been a slight decline in net income from 2023 to 2024, indicating potential pressure on profitability.
Balance Sheet
70
Positive
Reckitt maintains a moderate debt-to-equity ratio of 1.29, suggesting a balanced leverage position. The equity ratio is stable at 26.5%, indicating a reasonable level of equity financing. However, the return on equity has decreased to 21.3% in 2024, reflecting a decline in profitability relative to shareholder equity.
Cash Flow
80
Positive
The company has demonstrated strong cash flow generation capabilities, with a free cash flow of 2.22 billion in 2024. The free cash flow to net income ratio is favorable, and operating cash flow exceeds net income, indicating strong cash earnings. The free cash flow growth rate is stable, showing resilience despite a challenging revenue environment.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue10.49B14.17B14.61B14.45B13.23B13.99B
Gross Profit6.38B8.60B8.76B8.36B7.69B8.44B
EBITDA2.04B2.95B3.19B3.90B465.00M3.48B
Net Income763.00M1.43B1.64B2.33B-32.00M1.19B
Balance Sheet
Total Assets24.62B25.30B27.14B28.74B26.95B31.29B
Cash, Cash Equivalents and Short-Term Investments963.00M760.00M1.39B1.16B1.26B1.65B
Total Debt9.40B8.66B8.54B8.88B9.56B10.56B
Total Liabilities18.27B18.58B18.67B19.26B19.49B22.13B
Stockholders Equity6.31B6.70B8.45B9.44B7.40B9.12B
Cash Flow
Free Cash Flow1.78B2.22B2.19B1.95B1.32B3.12B
Operating Cash Flow2.11B2.68B2.64B2.40B1.70B3.52B
Investing Cash Flow-423.00M-396.00M-466.00M-139.00M239.00M-512.00M
Financing Cash Flow-1.96B-2.71B-1.81B-2.38B-2.29B-2.86B

Reckitt Technical Analysis

Technical Analysis Sentiment
Positive
Last Price5978.00
Price Trends
50DMA
5903.72
Positive
100DMA
5759.14
Positive
200DMA
5354.11
Positive
Market Momentum
MACD
36.77
Positive
RSI
53.07
Neutral
STOCH
41.59
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:RKT, the sentiment is Positive. The current price of 5978 is above the 20-day moving average (MA) of 5965.40, above the 50-day MA of 5903.72, and above the 200-day MA of 5354.11, indicating a bullish trend. The MACD of 36.77 indicates Positive momentum. The RSI at 53.07 is Neutral, neither overbought nor oversold. The STOCH value of 41.59 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:RKT.

Reckitt Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
£13.89B18.1428.56%1.96%6.00%42.42%
76
Outperform
£40.19B32.9117.41%3.44%-2.41%-16.41%
74
Outperform
£24.80B12.4540.35%5.57%2.69%-16.50%
72
Outperform
£105.52B22.7228.78%3.85%-2.98%-16.90%
71
Outperform
£91.56B30.326.03%5.67%-2.24%
69
Neutral
£14.99B14.929.22%2.98%-3.06%-26.93%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:RKT
Reckitt
5,978.00
1,364.46
29.58%
GB:ABF
Associated British Foods
2,113.00
137.22
6.95%
GB:BATS
British American Tobacco
4,215.00
1,485.58
54.43%
GB:CCH
Coca Cola HBC
3,822.00
1,144.32
42.74%
GB:IMB
Imperial Brands
3,126.00
721.72
30.02%
GB:ULVR
Unilever
4,838.00
143.41
3.05%

Reckitt Corporate Events

Shareholder MeetingsStock Buyback
Reckitt Benckiser Executes Share Buyback
Neutral
Dec 5, 2025

Reckitt Benckiser Group PLC has repurchased 58,800 of its ordinary shares from BNP Paribas SA, following shareholder approval at the Annual General Meeting. This transaction, executed under previously issued instructions, will see the shares held in treasury, affecting the total number of voting rights and shares in issue, which stakeholders can use to assess their interests in the company.

Stock Buyback
Reckitt Benckiser Executes Share Buyback
Neutral
Dec 4, 2025

Reckitt Benckiser Group PLC announced the repurchase of 58,810 ordinary shares from BNP Paribas SA, as authorized by shareholders at the recent Annual General Meeting. This transaction, executed under the company’s share buyback program, aims to hold the repurchased shares in treasury, impacting the total number of voting rights and potentially influencing shareholder interests.

Business Operations and Strategy
Reckitt Highlights Growth Strategy in Emerging Markets at Investor Seminar
Positive
Dec 4, 2025

Reckitt hosted an investor seminar titled ‘Reckitt Focus On: Emerging Markets,’ highlighting its strategy to drive sustainable growth in emerging markets through strong branding, premiumisation, and digital execution. The seminar, led by key company executives, aims to support Reckitt’s medium-term revenue growth targets, emphasizing the company’s commitment to leveraging innovation and market positioning.

Stock Buyback
Reckitt Benckiser Executes Share Buyback Program
Neutral
Dec 3, 2025

Reckitt Benckiser Group PLC announced the repurchase of 58,600 of its ordinary shares from BNP Paribas SA, as part of a buyback program authorized by shareholders. The shares will be held in treasury, affecting the total number of voting rights and potentially impacting shareholder interests as outlined by the FCA’s Disclosure Guidance and Transparency Rules.

Shareholder MeetingsStock Buyback
Reckitt Benckiser Executes Share Buyback
Neutral
Dec 2, 2025

Reckitt Benckiser Group PLC has repurchased 58,600 of its ordinary shares from BNP PARIBAS SA, as authorized by its shareholders during the Annual General Meeting in May 2025. This transaction, executed on December 1, 2025, will result in the company holding a total of 59,000,957 shares in treasury, impacting the total number of voting rights available to shareholders and aligning with regulatory requirements.

Regulatory Filings and Compliance
Reckitt Benckiser Updates on Voting Rights and Capital Structure
Neutral
Dec 1, 2025

Reckitt Benckiser Group PLC announced its current voting rights and capital structure, revealing that as of November 28, 2025, the company has 732,089,339 issued ordinary shares, with 58,822,847 held in treasury, resulting in total voting rights of 673,266,492. This information is crucial for shareholders and those with notification obligations under the FCA’s Disclosure Guidance and Transparency Rules, as it affects the calculation of their interests in the company.

Stock BuybackBusiness Operations and Strategy
Reckitt Benckiser Executes Share Buyback Strategy
Neutral
Dec 1, 2025

Reckitt Benckiser Group PLC has repurchased 59,860 of its ordinary shares from BNP Paribas SA, as authorized by shareholders earlier this year. This transaction, part of a broader strategy to manage its capital structure, results in the company holding a total of 58,942,357 shares in treasury, with 673,146,982 shares remaining in issue, impacting the total voting rights available to shareholders.

Stock BuybackBusiness Operations and Strategy
Reckitt Benckiser Executes Share Buyback to Enhance Financial Strategy
Neutral
Nov 28, 2025

Reckitt Benckiser Group PLC announced the repurchase of 59,650 of its ordinary shares, which will be held in treasury. This transaction, executed with BNP Paribas SA, was conducted under the authority granted by shareholders and impacts the company’s total voting rights, now totaling 673,206,842. This move may influence shareholder interests and aligns with the company’s strategic financial management.

Stock BuybackBusiness Operations and Strategy
Reckitt Benckiser Executes Share Buyback to Optimize Shareholder Value
Positive
Nov 27, 2025

Reckitt Benckiser Group PLC has repurchased 59,420 of its ordinary shares from BNP Paribas SA, as part of a shareholder-approved buyback plan. This transaction, which will see the shares held in treasury, impacts the company’s total voting rights, now standing at 673,265,438, and is part of its strategic financial management to optimize shareholder value.

Shareholder MeetingsStock Buyback
Reckitt Benckiser Executes Share Buyback
Neutral
Nov 26, 2025

Reckitt Benckiser Group PLC announced the repurchase of 59,770 of its ordinary shares from BNP Paribas SA, as authorized by shareholders at the company’s Annual General Meeting. The shares, bought at an average price of 5,854.93 pence per share, will be held in treasury, affecting the total number of voting rights available to shareholders.

Stock Buyback
Reckitt Benckiser Executes Share Buyback
Neutral
Nov 25, 2025

Reckitt Benckiser Group PLC announced the repurchase of 59,410 of its ordinary shares from BNP Paribas SA, as per the authority granted by shareholders at the company’s Annual General Meeting. The shares, purchased at a volume-weighted average price of 5,890.56 pence, will be held in treasury, impacting the total number of voting rights available to shareholders.

Stock BuybackRegulatory Filings and Compliance
Reckitt Executes Share Buyback, Updates Voting Rights
Neutral
Nov 24, 2025

Reckitt Benckiser Group PLC announced the purchase of 59,500 of its ordinary shares from BNP Paribas SA, as part of a share buyback program authorized by shareholders. This transaction, which will see the shares held in treasury, impacts the total number of voting rights in the company, providing shareholders with updated figures for regulatory purposes.

Stock BuybackBusiness Operations and Strategy
Reckitt Benckiser Executes Share Buyback Program
Neutral
Nov 21, 2025

Reckitt Benckiser Group PLC has repurchased 68,710 of its ordinary shares from BNP Paribas SA, as part of a buyback program authorized by shareholders. This transaction, executed on 20 November 2025, will see the repurchased shares held in treasury, affecting the total number of voting rights and shares in issue, which now stands at 673,503,538. This move is part of Reckitt’s ongoing efforts to manage its capital structure effectively.

Shareholder MeetingsStock Buyback
Reckitt Benckiser Executes Share Buyback, Adjusts Voting Rights
Neutral
Nov 20, 2025

Reckitt Benckiser Group PLC has repurchased 60,100 of its ordinary shares from BNP Paribas SA, following shareholder approval at its Annual General Meeting. This transaction, executed under previously issued instructions, results in the company holding a total of 58,517,091 shares in treasury, impacting the total voting rights available to shareholders.

Stock BuybackRegulatory Filings and Compliance
Reckitt Benckiser Executes Share Buyback, Adjusts Voting Rights
Neutral
Nov 19, 2025

Reckitt Benckiser Group PLC announced the repurchase of 60,000 of its ordinary shares from BNP Paribas SA, as per the authority granted at its Annual General Meeting. The shares, bought at prices ranging from 5,800 to 5,880 pence, will be held in treasury. This transaction adjusts the company’s total voting rights to 673,631,501, impacting shareholder notifications under the FCA’s rules.

Stock Buyback
Reckitt Benckiser Executes Share Buyback Program
Neutral
Nov 18, 2025

Reckitt Benckiser Group PLC has repurchased 59,720 of its ordinary shares from BNP Paribas SA, as part of a buyback program authorized by shareholders. The repurchased shares will be held in treasury, affecting the total number of voting rights and potentially impacting shareholder interests and market positioning.

Stock Buyback
Reckitt Benckiser Executes Share Buyback
Neutral
Nov 17, 2025

Reckitt Benckiser Group PLC announced the repurchase of 60,000 of its ordinary shares from BNP Paribas SA, as authorized by shareholders at the company’s Annual General Meeting. The shares will be held in treasury, impacting the total number of voting rights and shares in issue, which stakeholders can use to assess their interests in the company.

Stock BuybackBusiness Operations and Strategy
Reckitt Benckiser Executes Share Buyback Strategy
Neutral
Nov 14, 2025

Reckitt Benckiser Group PLC has repurchased 59,700 of its ordinary shares from BNP Paribas SA, as authorized by shareholders at the company’s Annual General Meeting. The shares, bought at a volume-weighted average price of 5,861.76 pence, will be held in treasury, adjusting the total number of voting rights to 673,811,221. This transaction is part of Reckitt’s strategic financial management, potentially impacting shareholder interests and market positioning by consolidating ownership and possibly influencing share value.

Stock Buyback
Reckitt Benckiser Executes Share Buyback Program
Neutral
Nov 13, 2025

Reckitt Benckiser Group PLC announced the repurchase of 59,440 of its ordinary shares from BNP Paribas SA, as part of a buyback program authorized by shareholders. The repurchased shares will be held in treasury, impacting the total voting rights and share distribution, which stakeholders can use to assess their interests in the company.

Stock BuybackBusiness Operations and Strategy
Reckitt Benckiser Executes Share Buyback to Optimize Capital Structure
Neutral
Nov 12, 2025

Reckitt Benckiser Group PLC announced the repurchase of 59,310 of its ordinary shares from BNP Paribas SA, as authorized by shareholders in May 2025. This transaction, executed on November 11, 2025, is part of Reckitt’s strategy to manage its capital structure, with the repurchased shares held in treasury. Following this transaction, Reckitt’s total number of voting rights stands at 673,929,083, which stakeholders can use to assess their interests in the company.

Stock BuybackBusiness Operations and Strategy
Reckitt Benckiser Executes Share Buyback to Enhance Financial Strategy
Neutral
Nov 11, 2025

Reckitt Benckiser Group PLC has repurchased 59,580 of its ordinary shares from BNP Paribas SA, as authorized by shareholders at the company’s Annual General Meeting. The repurchased shares will be held in treasury, affecting the total number of voting rights, which now stands at 673,988,238. This transaction is part of Reckitt’s strategic financial management, potentially impacting shareholder interests and market positioning.

Shareholder MeetingsStock Buyback
Reckitt Benckiser Executes Share Buyback to Hold in Treasury
Neutral
Nov 10, 2025

Reckitt Benckiser Group PLC has repurchased 59,970 of its ordinary shares from BNP Paribas SA, as authorized by shareholders at the company’s Annual General Meeting. These shares will be held in treasury, bringing the total number of treasury shares to 58,041,521. This transaction affects the total number of voting rights in the company, which will now be 674,047,818, a figure shareholders can use to assess their interest in the company under FCA regulations.

Stock BuybackBusiness Operations and Strategy
Reckitt Benckiser Executes Share Buyback to Enhance Capital Management
Neutral
Nov 7, 2025

Reckitt Benckiser Group PLC announced the repurchase of 59,665 of its ordinary shares from BNP Paribas SA, as authorized by shareholders at the company’s Annual General Meeting. The repurchased shares will be held in treasury, affecting the total number of voting rights, which will now be 674,107,788. This move is part of the company’s strategy to manage its share capital and potentially enhance shareholder value.

Stock Buyback
Reckitt Benckiser Announces Share Repurchase
Neutral
Nov 6, 2025

Reckitt Benckiser Group PLC announced the repurchase of 59,680 of its ordinary shares from BNP Paribas SA, following the authority granted at its Annual General Meeting. The shares will be held in treasury, impacting the total number of voting rights available to shareholders, which now stands at 674,167,453. This transaction is part of Reckitt’s ongoing efforts to manage its capital structure and could influence shareholder decisions regarding their interests in the company.

Stock BuybackBusiness Operations and Strategy
Reckitt Benckiser Executes Share Buyback Strategy
Neutral
Nov 5, 2025

Reckitt Benckiser Group PLC announced the repurchase of 60,160 of its ordinary shares from BNP Paribas SA, following shareholder approval from the company’s Annual General Meeting in May 2025. This transaction, part of a broader strategy to manage its share capital, results in the company holding a total of 57,862,430 shares in treasury, with 674,226,909 shares remaining in circulation, impacting the voting rights and shareholder notifications under the FCA’s rules.

Stock BuybackRegulatory Filings and Compliance
Reckitt Benckiser Executes Share Buyback, Adjusts Voting Rights
Neutral
Nov 4, 2025

Reckitt Benckiser Group PLC has repurchased 60,000 of its ordinary shares from BNP Paribas SA, as per the authority granted at its Annual General Meeting. These shares will be held in treasury, adjusting the total number of voting rights to 674,286,437, which stakeholders can use for regulatory notifications.

Regulatory Filings and Compliance
Reckitt Benckiser Announces Total Voting Rights Update
Neutral
Nov 3, 2025

Reckitt Benckiser Group PLC announced its total voting rights as of October 31, 2025, in compliance with the Disclosure Guidance and Transparency Rules. The company has 732,089,339 issued ordinary shares, with 57,623,574 held in treasury, resulting in total voting rights of 674,465,765. This information is crucial for shareholders and others with notification obligations to determine their interest in the company.

Stock Buyback
Reckitt Benckiser Executes Share Buyback Program
Neutral
Nov 3, 2025

Reckitt Benckiser Group PLC has repurchased 60,215 of its ordinary shares from BNP Paribas SA, as part of a buyback program authorized by shareholders. The repurchased shares will be held in treasury, impacting the total number of voting rights and potentially influencing shareholder interests under regulatory guidelines.

Stock Buyback
Reckitt Benckiser Executes Share Buyback Program
Neutral
Oct 31, 2025

Reckitt Benckiser Group PLC announced the repurchase of 60,120 of its ordinary shares from BNP Paribas SA, as part of a buyback program authorized by shareholders. The shares, purchased at a volume-weighted average price of 5,819.55 pence per share, will be held in treasury, affecting the company’s total voting rights and potentially impacting shareholder interests in line with FCA’s Disclosure Guidance and Transparency Rules.

Executive/Board ChangesRegulatory Filings and Compliance
Reckitt Announces Director Share Purchase
Neutral
Oct 30, 2025

Reckitt Benckiser Group PLC announced a transaction involving the purchase of ordinary shares by Pat Verduin, a Non-Executive Director. The transaction, conducted on the London Stock Exchange, involved the acquisition of 135 shares at a price of £58.67 each, totaling £7,920.45. This notification is part of the company’s compliance with market regulations, reflecting transparency in managerial transactions and potentially impacting stakeholder perceptions of the company’s governance practices.

Stock BuybackRegulatory Filings and Compliance
Reckitt Benckiser Executes Share Buyback Program
Neutral
Oct 30, 2025

Reckitt Benckiser Group PLC has repurchased 59,520 of its ordinary shares from BNP Paribas SA, as part of a buyback program authorized by shareholders. This transaction, executed on 29 October 2025, will see the repurchased shares held in treasury, impacting the company’s total voting rights and potentially influencing shareholder interests under the FCA’s Disclosure Guidance and Transparency Rules.

Stock BuybackBusiness Operations and Strategy
Reckitt Benckiser Executes Share Buyback to Optimize Capital Structure
Neutral
Oct 29, 2025

Reckitt Benckiser Group PLC has repurchased 59,500 of its ordinary shares, which will be held in treasury. This transaction, executed in line with shareholder authority from the May 2025 Annual General Meeting, impacts the company’s total voting rights, now standing at 674,524,429. This move is part of Reckitt’s broader strategy to manage its capital structure and may influence shareholder interests and market perceptions.

Stock Buyback
Reckitt Benckiser Executes Share Buyback Program
Neutral
Oct 28, 2025

Reckitt Benckiser Group PLC announced the repurchase of 59,300 of its ordinary shares from BNP Paribas SA, as part of a buyback program authorized by shareholders. This transaction, completed on 27 October 2025, will see the repurchased shares held in treasury, impacting the total number of voting rights and shares in issue, which stakeholders can use to assess their interests in the company.

Stock BuybackBusiness Operations and Strategy
Reckitt Benckiser Executes Share Buyback to Optimize Shareholder Value
Positive
Oct 27, 2025

Reckitt Benckiser Group PLC announced the repurchase of 59,200 of its ordinary shares from BNP Paribas SA, as part of a shareholder-approved buyback program. This transaction, which will see the shares held in treasury, impacts the company’s total voting rights, now standing at 674,643,229, and reflects Reckitt’s strategic financial management aimed at optimizing shareholder value.

Stock BuybackBusiness Operations and Strategy
Reckitt Benckiser Announces Share Repurchase to Optimize Capital Structure
Neutral
Oct 24, 2025

Reckitt Benckiser Group PLC announced the repurchase of 59,700 of its ordinary shares, which will be held in treasury. This transaction, executed under the authority granted by shareholders, affects the company’s total voting rights, now standing at 674,702,429. This move is part of Reckitt’s broader strategy to manage its capital structure and could impact shareholder interests by altering the denominator used for determining voting rights.

Stock BuybackBusiness Operations and Strategy
Reckitt Benckiser Executes Share Buyback Strategy
Neutral
Oct 23, 2025

Reckitt Benckiser Group PLC has repurchased 59,400 of its ordinary shares from BNP Paribas SA, as authorized by shareholders in May 2025. The repurchased shares will be held in treasury, impacting the total number of voting rights, which now stands at 674,762,129. This transaction reflects the company’s ongoing strategy to manage its share capital effectively.

Stock Buyback
Reckitt Completes First Tranche of Share Buyback, Begins Second Phase
Neutral
Oct 22, 2025

Reckitt Benckiser Group PLC has successfully completed the first tranche of its £1 billion share buyback program, purchasing and canceling 4,445,840 ordinary shares at an average price of £56.23. The second tranche, managed by BNP Paribas, will commence on 22 October 2025, aiming to return up to £250 million to shareholders and reduce the company’s share capital, with shares held in treasury until cancellation upon completion.

Stock BuybackBusiness Operations and StrategyFinancial Disclosures
Reckitt Reports Strong Q3 Performance with Strategic Growth in Emerging Markets
Positive
Oct 22, 2025

Reckitt reported a robust third-quarter performance for 2025, with a 6.7% increase in like-for-like net revenue in its Core Reckitt segment, driven by significant growth in emerging markets and a return to growth in developed markets. The company is executing its strategic objectives to become a leading consumer health and hygiene company, with innovations in categories such as Intimate Wellness and Self Care contributing to growth. Despite challenges in certain regions, Reckitt maintains its full-year guidance, expecting continued growth and profitability, supported by a £1 billion share buyback program and ongoing strategic divestments.

Stock Buyback
Reckitt Benckiser Executes Share Buyback Plan
Neutral
Oct 21, 2025

Reckitt Benckiser Group PLC announced the purchase of 55,098 of its own ordinary shares from RBC Europe Limited, as part of a shareholder-approved buyback program. The company plans to cancel these shares, impacting the total number of voting rights and shares in issue, which may affect shareholder interests and market perceptions.

Stock BuybackBusiness Operations and Strategy
Reckitt Benckiser Executes Share Buyback Plan
Neutral
Oct 20, 2025

Reckitt Benckiser Group PLC announced the purchase of 59,790 of its ordinary shares from RBC Europe Limited, as authorized by its shareholders. The company plans to cancel these shares, impacting its total voting rights, which will now stand at 674,926,273. This move is part of the company’s strategy to manage its share capital and could affect shareholder interests by altering the denominator used for determining voting rights.

Stock BuybackBusiness Operations and Strategy
Reckitt Benckiser Executes Share Buyback to Enhance Shareholder Value
Positive
Oct 17, 2025

Reckitt Benckiser Group PLC announced the repurchase of 69,301 ordinary shares as part of its ongoing share buyback program. The shares, purchased at prices ranging from 5,734.00 to 5,816.00 pence, will be canceled, reducing the total number of shares in circulation and potentially enhancing shareholder value by increasing the earnings per share. This move aligns with the company’s strategy to optimize its capital structure and return value to shareholders.

Stock BuybackBusiness Operations and Strategy
Reckitt Benckiser Executes Share Buyback to Optimize Capital Structure
Neutral
Oct 16, 2025

Reckitt Benckiser Group PLC announced the purchase of 69,262 of its ordinary shares from RBC Europe Limited, as per the authority granted by shareholders in May 2025. The company plans to cancel these shares, which will result in 675,055,364 ordinary shares in issue, excluding treasury shares. This transaction is part of Reckitt’s strategy to manage its share capital and maintain shareholder value, impacting the total number of voting rights and potentially influencing shareholder interests.

Stock Buyback
Reckitt Benckiser Executes Share Buyback and Cancellation
Neutral
Oct 15, 2025

Reckitt Benckiser Group PLC announced the repurchase of 69,900 of its ordinary shares from RBC Europe Limited, with plans to cancel these shares. This transaction, conducted under the authority granted at the company’s Annual General Meeting, will adjust the total number of voting rights, impacting shareholder calculations under the FCA’s Disclosure Guidance and Transparency Rules.

Stock Buyback
Reckitt Benckiser Executes Share Buyback to Enhance Shareholder Value
Positive
Oct 14, 2025

Reckitt Benckiser Group PLC has repurchased 69,400 of its ordinary shares as part of a buyback program authorized by shareholders. The repurchased shares will be canceled, reducing the total number of shares in circulation and potentially increasing the value of remaining shares, which may impact shareholder voting rights and market perception.

Stock BuybackBusiness Operations and Strategy
Reckitt Benckiser Announces Share Buyback and Cancellation
Positive
Oct 13, 2025

Reckitt Benckiser Group PLC has repurchased 69,800 of its ordinary shares as part of a buyback program authorized by shareholders. The company plans to cancel these shares, which will result in a total of 675,262,729 voting rights. This move is part of Reckitt’s strategy to manage its share capital and potentially enhance shareholder value.

Stock Buyback
Reckitt Benckiser Announces Share Repurchase and Cancellation
Neutral
Oct 10, 2025

Reckitt Benckiser Group PLC has repurchased 70,500 of its ordinary shares from RBC Europe Limited, as per the authority granted at its Annual General Meeting. The company plans to cancel these shares, which will adjust its total voting rights to 675,332,529, potentially impacting shareholder notifications under FCA rules.

Stock Buyback
Reckitt Benckiser Announces Share Repurchase and Cancellation
Neutral
Oct 9, 2025

Reckitt Benckiser Group PLC announced the repurchase of 67,093 of its ordinary shares from RBC Europe Limited, with the highest price paid per share being 5,674 pence. The company plans to cancel these shares, resulting in a total of 675,403,029 ordinary shares in issue, excluding treasury shares, which will affect the total number of voting rights and potentially influence shareholder interests.

Stock BuybackBusiness Operations and Strategy
Reckitt Benckiser Executes Share Buyback Strategy
Neutral
Oct 8, 2025

Reckitt Benckiser Group PLC announced the purchase of 70,500 of its ordinary shares from RBC Europe Limited, as authorized by its shareholders. The company plans to cancel these shares, impacting the total number of voting rights, which will now stand at 675,469,063. This move is part of Reckitt’s strategy to manage its share capital and could influence shareholder interests and market positioning.

Stock BuybackRegulatory Filings and Compliance
Reckitt Benckiser Executes Share Buyback to Adjust Voting Rights
Neutral
Oct 7, 2025

Reckitt Benckiser Group PLC announced the purchase of 70,500 of its ordinary shares from RBC Europe Limited, with plans to cancel these shares. This move will adjust the total number of voting rights to 675,539,563, impacting shareholder calculations under the FCA’s Disclosure Guidance and Transparency Rules.

Stock Buyback
Reckitt Benckiser Executes Share Buyback and Cancellation
Neutral
Oct 6, 2025

Reckitt Benckiser Group PLC announced the purchase of 70,000 of its ordinary shares from RBC Europe Limited, with the intention to cancel these shares. This transaction, authorized by shareholders, will adjust the total number of voting rights to 675,610,063, potentially impacting shareholder notifications under the FCA’s rules.

Stock BuybackBusiness Operations and Strategy
Reckitt Benckiser Adjusts Share Capital with Strategic Buyback
Positive
Oct 3, 2025

Reckitt Benckiser Group PLC announced the repurchase of 70,000 of its ordinary shares, with plans to cancel them, thereby adjusting its share capital structure. This move is part of a strategic initiative to manage its equity and potentially enhance shareholder value, impacting the total voting rights and share distribution.

Stock Buyback
Reckitt Benckiser Adjusts Share Capital with Recent Buyback
Neutral
Oct 2, 2025

Reckitt Benckiser Group PLC announced the purchase of 66,221 of its ordinary shares, with plans to cancel them, thereby adjusting its share capital structure. This move will result in 675,749,862 ordinary shares in issue, impacting the total voting rights and potentially influencing shareholder decisions under the FCA’s Disclosure Guidance and Transparency Rules.

Regulatory Filings and Compliance
Reckitt Benckiser Updates Shareholders on Voting Rights
Neutral
Oct 1, 2025

Reckitt Benckiser Group PLC announced its total voting rights as of September 30, 2025, in compliance with the Disclosure Guidance and Transparency Rules. The company has 733,238,235 issued ordinary shares, with 57,271,148 held in treasury, resulting in 675,967,087 total voting rights. This figure is crucial for shareholders and others with notification obligations to determine their interest in the company under regulatory guidelines.

Stock BuybackBusiness Operations and Strategy
Reckitt Benckiser Executes Share Buyback Strategy
Neutral
Sep 30, 2025

Reckitt Benckiser Group PLC announced the purchase of 81,000 of its ordinary shares from RBC Europe Limited, as authorized by shareholders during the company’s Annual General Meeting. The shares were acquired at a volume-weighted average price of 5,529.29 pence per share and will be canceled, affecting the total number of shares in issue and voting rights. This transaction is part of Reckitt’s strategy to manage its share capital and potentially enhance shareholder value.

Stock BuybackBusiness Operations and Strategy
Reckitt Initiates Second Tranche of £1 Billion Share Buyback Programme
Positive
Sep 26, 2025

Reckitt Benckiser Group PLC has announced the commencement of the second tranche of its £1 billion 2025 share buyback programme, aimed at increasing shareholder returns and reducing share capital. The second tranche, managed by BNP Paribas, will return an additional £250 million to shareholders and is expected to conclude by January 2026. This strategic move is part of Reckitt’s ongoing efforts to strengthen its market position and deliver value to its stakeholders.

Stock BuybackBusiness Operations and Strategy
Reckitt Benckiser Executes Share Buyback to Optimize Capital Structure
Neutral
Sep 26, 2025

Reckitt Benckiser Group PLC announced the repurchase of 80,000 of its ordinary shares from RBC Europe Limited, as authorized by shareholders at the company’s Annual General Meeting. The repurchased shares, bought at a volume-weighted average price of 5,590.52 pence, will be canceled, reducing the total number of shares in issue and affecting the voting rights structure. This move is part of the company’s ongoing efforts to manage its capital structure and may influence shareholder interest and market perceptions.

Stock BuybackBusiness Operations and Strategy
Reckitt Benckiser Executes Share Buyback to Optimize Capital Structure
Positive
Sep 25, 2025

Reckitt Benckiser Group PLC announced the repurchase of 80,000 ordinary shares as part of a buyback program authorized by shareholders. The shares were purchased at a volume-weighted average price of 5,565.14 pence and will be canceled, impacting the total number of voting rights and shares in issue. This move is part of the company’s strategy to manage its capital structure and enhance shareholder value.

Stock BuybackBusiness Operations and Strategy
Reckitt Benckiser Executes Share Buyback to Optimize Capital Structure
Positive
Sep 24, 2025

Reckitt Benckiser Group PLC announced the purchase of 70,000 of its ordinary shares from RBC Europe Limited, as part of a buyback program authorized by shareholders. The company intends to cancel these shares, which will adjust the total number of voting rights to 676,200,177. This move is part of Reckitt’s strategy to manage its capital structure and potentially enhance shareholder value.

Stock BuybackBusiness Operations and Strategy
Reckitt Benckiser Executes Share Buyback Strategy
Neutral
Sep 23, 2025

Reckitt Benckiser Group PLC announced the purchase of 70,000 of its ordinary shares from RBC Europe Limited, following shareholder approval at the Annual General Meeting. The company plans to cancel these shares, impacting the total number of voting rights, which will be 676,270,177. This move is part of Reckitt’s strategy to manage its share capital and could influence shareholder interests and market positioning.

DividendsBusiness Operations and Strategy
Reckitt Executives Acquire Shares, Signaling Confidence in Future Performance
Positive
Sep 22, 2025

Reckitt Benckiser Group PLC announced the acquisition of shares by its CEO, Kris Licht, and CFO, Shannon Eisenhardt, through the company’s Dividend Reinvestment Plan. This transaction highlights the executives’ confidence in the company’s future performance and aligns their interests with those of the shareholders, potentially strengthening stakeholder trust and market positioning.

Stock Buyback
Reckitt Benckiser Executes Share Buyback and Cancellation
Neutral
Sep 22, 2025

Reckitt Benckiser Group PLC has repurchased 70,000 of its ordinary shares from RBC Europe Limited, as authorized by its shareholders. The company plans to cancel these shares, resulting in a total of 676,340,177 voting rights, which shareholders can use to assess their interest in the company under the FCA’s rules.

Shareholder MeetingsStock Buyback
Reckitt Benckiser Executes Share Buyback and Cancellation
Neutral
Sep 19, 2025

Reckitt Benckiser Group PLC announced the purchase of 70,000 of its ordinary shares from RBC Europe Limited, following shareholder approval at its Annual General Meeting. The shares will be canceled, adjusting the total number of voting rights to 676,410,177, impacting shareholder notifications under the FCA’s Disclosure Guidance and Transparency Rules.

Stock BuybackRegulatory Filings and Compliance
Reckitt Benckiser Announces Share Repurchase and Cancellation
Neutral
Sep 18, 2025

Reckitt Benckiser Group PLC has repurchased 70,000 of its ordinary shares from RBC Europe Limited, following shareholder approval at its Annual General Meeting. The company plans to cancel these shares, which will adjust the total number of voting rights to 676,480,177, impacting shareholder interests and regulatory disclosures.

Stock Buyback
Reckitt Benckiser Announces Share Buyback and Cancellation
Neutral
Sep 17, 2025

Reckitt Benckiser Group PLC announced the purchase of 69,900 of its own ordinary shares from RBC Europe Limited, with the intention to cancel these shares. This move, authorized by shareholders, will result in the company holding 57,272,268 shares in treasury and 676,550,177 shares in issue, impacting the total number of voting rights and potentially influencing shareholder interests.

Stock Buyback
Reckitt Benckiser Executes Share Buyback and Cancellation
Neutral
Sep 16, 2025

Reckitt Benckiser Group PLC announced the purchase of 69,300 of its ordinary shares from RBC Europe Limited, as authorized by its shareholders. The company intends to cancel these shares, adjusting its total voting rights to 676,620,077, which impacts shareholder notifications under the FCA’s rules.

Stock BuybackBusiness Operations and Strategy
Reckitt Benckiser Executes Share Buyback to Enhance Shareholder Value
Positive
Sep 15, 2025

Reckitt Benckiser Group PLC has repurchased 69,400 of its ordinary shares from RBC Europe Limited, as part of a buyback program authorized by shareholders in May 2025. The shares, purchased at an average price of 5,770.68 pence, will be canceled, reducing the total number of shares in circulation and potentially increasing the value of remaining shares. This transaction is part of Reckitt’s strategy to manage its capital structure and enhance shareholder value.

Stock Buyback
Reckitt Benckiser Executes Share Buyback Program
Neutral
Sep 12, 2025

Reckitt Benckiser Group PLC announced the purchase of 69,300 of its ordinary shares from RBC Europe Limited, as part of a share buyback program authorized by shareholders. The shares will be canceled, reducing the total number of shares in issue and potentially impacting shareholder voting rights and interest notifications.

Stock Buyback
Reckitt Benckiser Announces Share Repurchase and Cancellation
Neutral
Sep 11, 2025

Reckitt Benckiser Group PLC has repurchased 69,100 of its ordinary shares from RBC Europe Limited, with plans to cancel these shares. This transaction, authorized by shareholders in May 2025, will adjust the total number of voting rights to 676,828,077, impacting shareholder notifications under FCA regulations.

Stock BuybackBusiness Operations and Strategy
Reckitt Benckiser Announces Share Buyback and Cancellation
Neutral
Sep 10, 2025

Reckitt Benckiser Group PLC announced the purchase of 57,920 of its ordinary shares from RBC Europe Limited, as authorized by its shareholders. The company plans to cancel these shares, resulting in a total of 676,894,515 voting rights. This move is part of Reckitt’s strategy to manage its share capital effectively, potentially impacting its market positioning and shareholder value.

Stock BuybackBusiness Operations and Strategy
Reckitt Benckiser Executes Share Buyback to Optimize Capital Structure
Neutral
Sep 9, 2025

Reckitt Benckiser Group PLC announced the purchase of 68,600 of its ordinary shares from RBC Europe Limited, as part of a buyback program authorized by shareholders. The company plans to cancel these shares, impacting the total voting rights and share count, which will now stand at 676,952,435. This move is part of Reckitt’s strategy to manage its capital structure and potentially enhance shareholder value.

Private Placements and FinancingBusiness Operations and Strategy
Reckitt Successfully Prices Senior Notes to Strengthen Market Position
Positive
Sep 8, 2025

Reckitt Benckiser Group PLC announced the successful launch and pricing of senior notes totaling EUR 1.35 billion and GBP 250 million under its Euro Medium Term Note Programme. This strategic financial move is expected to support Reckitt’s ongoing operations and reinforce its market position in the consumer health and hygiene industry.

Stock BuybackBusiness Operations and Strategy
Reckitt Benckiser Announces Share Buyback and Cancellation
Neutral
Sep 8, 2025

Reckitt Benckiser Group PLC announced the purchase of 70,447 of its ordinary shares from RBC Europe Limited, following shareholder approval at the Annual General Meeting in May 2025. The company plans to cancel these shares, impacting the total number of voting rights, which will now be 677,021,035. This move is part of Reckitt’s ongoing strategy to manage its share capital and potentially enhance shareholder value.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 07, 2025